ArcticZymes - About the company
ArcticZymes is a public company based in Tromso (Norway), founded in 2009. It operates as a Developer of recombinant enzymes from various arctic species. ArcticZymes has raised an undisclosed amount in funding. The company has 492 active competitors, including 52 funded and 86 that have exited. Its top competitors include companies like BioLife Solutions, Enzo and Integrated DNA Technologies.
Company Details
Developer of recombinant enzymes from various arctic species. The product line of the company includes COD Uracil DNA glycosylase, Salt active nuclease, Double-strand specific DNAases, Iso Pol DNA Polymerase, and Shrimp Alkaline Phosphatase (heat-labile enzyme). The following are the examples of some of the research applications of these products Removal of genomic DNA from RNA preparations, Decontamination of PCR master mixes, Dephosphorylation prior to cloning, PCR carry-over prevention, Protein Purification, Complete removal of DNA, PCR product clean-up, and Viscosity reduction.
- Website
- www.arcticzymes.com/
- Email ID
- *****@arcticzymes.com
- Phone Number
- +47 **********
- Registered Address
- Forskningsparken, 9019, TROMSØ
Key Metrics
Founded Year
2009
Location
Tromso, Norway
Stage
Public
Latest Funding Round
Investors
Ranked
22nd among 492 active competitors
Employee Count
51 as on Jul 31, 2026
Similar Companies
Exit Details
Public
Legal entities associated with ArcticZymes
ArcticZymes is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Arcticzymes As CIN: 994191632 , Norway, Active | Jun 02, 2009 | - | 57 (As on Dec 31, 2022) | |
ARCTICZYMES TECHNOLOGIES ASA CIN: 959033560 , Norway, Active | - | - | ||
ARCTICZYMES TECHNOLOGIES ASA CIN: 959033560 , Norway, Active | Oct 31, 1990 | - | - |
ArcticZymes's IPO details
ArcticZymes got listed on Nov 16, 2007.
Click here to take a look at ArcticZymes's IPO in detail
Sign up to download ArcticZymes' company profile
ArcticZymes's funding and investors
ArcticZymes has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Apr 01, 2016 for $*****. 1 investor participated in its latest round. ArcticZymes has 2 institutional investors.
Here is the list of recent funding rounds of ArcticZymes:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 01, 2016 | 9368299 | Grant (prize money) | 7333335 | 4830927 | 7235833 | 9329685 |
View details of ArcticZymes's funding rounds and investors
ArcticZymes' founders and board of directors
Founder? Claim ProfileArcticZymes' employee count trend
ArcticZymes has 51 employees as of Jul 26. Here is ArcticZymes's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ArcticZymes's Competitors and alternates
Top competitors of ArcticZymes include BioLife Solutions, Enzo and Integrated DNA Technologies. Here is the list of Top 10 competitors of ArcticZymes, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
2nd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
3rd | Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 63/100 | |
4th | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
5th | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
6th | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 58/100 | |
7th | RoosterBio 2012, Frederick (United States), Series B | Developer of human mesenchymal stem cells and extracellular vesicles | $38.4M | 57/100 | |
8th | BioIVT 1981, Westbury (United States), Acquired | Provider of in vitro diagnostic products and assay services | - | 56/100 | |
9th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
10th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 56/100 | |
22nd | ArcticZymes 2009, Tromso (Norway), Public | Developer of recombinant enzymes from various arctic species | - | 49/100 |
Looking for more details on ArcticZymes's competitors? Click here to see the top ones
ArcticZymes's Investments and acquisitions
ArcticZymes has made no investments or acquisitions yet.
Reports related to ArcticZymes
Here is the latest report on ArcticZymes's sector:
News related to ArcticZymes
Media has covered ArcticZymes for a total of 7 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
•
•
•
•
•
•
•
•
•
Are you a Founder ?
FAQs about ArcticZymes
Explore our recently published companies
- Frukt AS - Norway based, Unfunded company
- Ojha Sir Gyanshala - Unfunded company
- Ozeku - Unfunded company
- Mainmeditech - China based, 2020 founded, Unfunded company
- MOBYLIZ - France based, 2020 founded, Unfunded company
- Dave Carmack - Unfunded company